Inventor · disambiguated record
Neville J. Anthony
Also filed as: ANTHONY NEVILLE · ANTHONY NEVILLE J · ANTHONY NEVILLE JOHN
69 granted patents·18 pending applications·2,676 citations·filing 1991–2024
99Inventor score
Files withMERCK & CO INC37MERCK SHARP & DOHME19FOGHORN THERAPEUTICS INC7ENKO CHEM INC5REVOLUTION MEDICINES INC5
Top patents by PatentIndex Score
87 records- 0197US6093737AInhibitors of farnesyl-protein transferaseMERCK & CO INC·Filed 1997·Granted Jul 25, 2000·175 cites·20 claims
- 0297US6051574AInhibitors of farnesyl-protein transferaseMERCK & CO INC·Filed 1999·Granted Apr 18, 2000·112 cites·28 claims
- 0397US5891889AInhibitors of farnesyl-protein transferaseMERCK & CO INC·Filed 1997·Granted Apr 6, 1999·132 cites·16 claims
- 0497US5856326AInhibitors of farnesyl-protein transferaseMERCK & CO INC·Filed 1996·Granted Jan 5, 1999·280 cites·13 claims
- 0597US5854265ABiheteroaryl inhibitors of farnesyl-protein transferaseMERCK & CO INC·Filed 1997·Granted Dec 29, 1998·142 cites·23 claims
- 0697US5854264AInhibitors of farnesyl-protein transferaseMERCK & CO INC·Filed 1997·Granted Dec 29, 1998·144 cites·15 claims
- 0797US5852010AInhibitors of farnesyl-protein transferaseMERCK & CO INC·Filed 1997·Granted Dec 22, 1998·101 cites·4 claims
- 0897US5756528AInhibitors of farnesyl-protein transferaseMERCK & CO INC·Filed 1996·Granted May 26, 1998·149 cites·21 claims
- 0996US6248756B1Inhibitors of farnesyl-protein transferaseMERCK & CO INC·Filed 1999·Granted Jun 19, 2001·101 cites·11 claims
- 1096US6063930ASubstituted imidazole compounds useful as farnesyl-protein transferase inhibitorsMERCK & CO INC·Filed 1997·Granted May 16, 2000·114 cites·37 claims
- 1196US5883105AInhibitors of farnesyl-protein transferaseMERCK & CO INC·Filed 1997·Granted Mar 16, 1999·83 cites·28 claims
- 1296US5872136AArylheteroaryl inhibitors of farnesyl-protein transferaseMERCK & CO INC·Filed 1997·Granted Feb 16, 1999·115 cites·30 claims
- 1395US11497752B2Compounds and uses thereofFOGHORN THERAPEUTICS INC·Filed 2019·Granted Nov 15, 2022·7 cites·6 claims
- 1495US10466249B2Methods and reagents for analyzing protein-protein interfacesWARP DRIVE BIO INC·Filed 2018·Granted Nov 5, 2019·23 cites·2 claims
- 1595US9989535B2Methods and reagents for analyzing protein-protein interfacesWARP DRIVE BIO INC·Filed 2016·Granted Jun 5, 2018·23 cites·4 claims
- 1695US6080870ABiaryl substituted imidazole compounds useful as farnesyl-protein transferase inhibitorsMERCK & CO INC·Filed 1997·Granted Jun 27, 2000·105 cites·36 claims
- 1795US5880140ABiheteroaryl inhibitors of farnesyl-protein transferaseMERCK & CO INC·Filed 1997·Granted Mar 9, 1999·84 cites·19 claims
- 1894US10948495B2Methods and reagents for analyzing protein-protein interfacesREVOLUTION MEDICINES INC·Filed 2018·Granted Mar 16, 2021·12 cites·4 claims
- 1994US9663522B23-aminocycloalkyl compounds as RORgammaT inhibitors and uses thereofMERCK SHARP & DOHME·Filed 2013·Granted May 30, 2017·15 cites·22 claims
- 2093US10039839B2Compounds that participate in cooperative binding and uses thereofWARP DRIVE BIO INC·Filed 2016·Granted Aug 7, 2018·18 cites·3 claims
- 2193US5874452ABiheteroaryl inhibitors of farnesyl-protein transferaseMERCK & CO INC·Filed 1997·Granted Feb 23, 1999·69 cites·28 claims
- 2293US5859035AArylheteroaryl inhibitors of farnesyl-protein transferaseMERCK & CO INC·Filed 1997·Granted Jan 12, 1999·81 cites·31 claims
- 2392US12383560B2Compounds and uses thereofFOGHORN THERAPEUTICS INC·Filed 2022·Granted Aug 12, 2025·1 cites·10 claims
- 2492US11889833B2Protoporphyrinogen oxidase inhibitorsENKO CHEM INC·Filed 2023·Granted Feb 6, 2024·2 cites·25 claims
- 2592US10221146B2Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of diseaseMERCK SHARP & DOHME·Filed 2017·Granted Mar 5, 2019·6 cites·18 claims
- 2692US9809561B2Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of diseaseMERCK SHARP & DOHME·Filed 2014·Granted Nov 7, 2017·8 cites·16 claims
- 2792US9663502B22-Acylamidomethyl and sulfonylamidomethyl benzoxazine carbamates for inhibition of RORgamma activity and the treatment of diseaseMERCK SHARP & DOHME·Filed 2014·Granted May 30, 2017·12 cites·26 claims
- 2891US6919351B2Aza-and polyaza-naphthalenyl-carboxamides useful as HIV integrase inhibitorsMERCK & CO INC·Filed 2001·Granted Jul 19, 2005·46 cites·10 claims
- 2991US6841558B2Aza-and polyaza-naphthalenyl carboxamides useful as HIV intergrase inhibitorsMERCK & CO INC·Filed 2001·Granted Jan 11, 2005·41 cites·10 claims
- 3091US5939557AInhibitors of farnesyl-protein transferaseMERCK & CO INC·Filed 1997·Granted Aug 17, 1999·67 cites·28 claims
- 3190US9556168B2N-alkylated indole and indazole compounds as RORgammaT inhibitors and uses thereofMERCK SHARP & DOHME·Filed 2013·Granted Jan 31, 2017·16 cites·23 claims
- 3290US7393873B2Arylsulfonamide derivativesMERCK & CO INC·Filed 2004·Granted Jul 1, 2008·32 cites·11 claims
- 3390US5574025AInhibitors of prenyl-protein transferasesMERCK & CO INC·Filed 1994·Granted Nov 12, 1996·36 cites·4 claims
- 3489US9487490B23-cyclohexenyl and cyclohexyl substituted indole and indazole compounds as RORgammaT inhibitors and uses thereofMERCK SHARP & DOHME·Filed 2013·Granted Nov 8, 2016·15 cites·24 claims
- 3589US5939439AInhibitors of farnesyl-protein transferaseMERCK & CO INC·Filed 1997·Granted Aug 17, 1999·42 cites·21 claims
- 3688US6921759B2Aza- and polyaza-naphthalenyl carboxamides useful as HIV integrase inhibitorsMERCK & CO INC·Filed 2001·Granted Jul 26, 2005·41 cites·23 claims
- 3787US2025085291A1Methods and reagents for analyzing protein-protein interfacesREVOLUTION MEDICINES INC·Filed 2024·Application pending·0 cites
- 3886US9745265B24-heteroaryl substituted benzoic acid compounds as RORgammaT inhibitors and uses thereofMERCK SHARP & DOHME·Filed 2013·Granted Aug 29, 2017·9 cites·29 claims
- 3986US8796310B2Amino-pyridine-containing spleen tyrosine kinase (SYK) inhibitorsROMEO ERIC THOMAS·Filed 2012·Granted Aug 5, 2014·16 cites·38 claims
- 4084US2025121077A1Compounds that participate in cooperative binding and uses thereofREVOLUTION MEDICINES INC·Filed 2024·Application pending·0 cites
- 4181US6919343B2N-biphenyl(substituted methyl) aminocycloalkane-carboxamide derivativesMERCK & CO INC·Filed 2003·Granted Jul 19, 2005·14 cites·40 claims
- 4280US11827610B2Protoporphyrinogen oxidase inhibitorsENKO CHEM INC·Filed 2023·Granted Nov 28, 2023·0 cites·25 claims
- 4380US5998407AInhibitors of farnesyl-protein transferaseMERCK & CO INC·Filed 1998·Granted Dec 7, 1999·22 cites·13 claims
- 4479US12302900B2Protoporphyrinogen oxidase inhibitorsENKO CHEM INC·Filed 2023·Granted May 20, 2025·0 cites·37 claims
- 4578US10196354B24-heteroaryl substituted benzoic acid compounds as RORgammaT inhibitors and uses thereofMERCK SHARP & DOHME·Filed 2017·Granted Feb 5, 2019·2 cites·29 claims
- 4678US8404856B2Non-nucleoside reverse transcriptase inhibitorsTUCKER THOMAS J·Filed 2008·Granted Mar 26, 2013·8 cites·6 claims
- 4778US5661161AInhibitors of farnesyl-protein transferaseMERCK & CO INC·Filed 1995·Granted Aug 26, 1997·30 cites·44 claims
- 4876US7781454B2Non-nucleoside reverse transcriptase inhibitorsMERCK SHARP & DOHME·Filed 2007·Granted Aug 24, 2010·2 cites·18 claims
- 4975US2021405060A1Methods and reagents for analyzing protein-protein interfacesREVOLUTION MEDICINES INC·Filed 2021·Application pending·0 cites
- 5075US2023382876A1Protoporphyrinogen oxidase inhibitorsENKO CHEM INC·Filed 2023·Application pending·0 cites
Showing the top 50 of 87 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Neville J. Anthony files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →